Article
Interplay of BRAF and TERT promoter mutations and Ki67 proliferation index in papillary thyroid carcinoma in Central Asians.
BMC endocrine disorders - 21 May 2026
Targynova Akbota, Mussazhanova Zhanna, Bychkov Andrey, Kurohama Hirokazu, Tlegenov Askar, Adilbay Dauren, Yeleubayeva Zhanar, Dushimova Zaure, Akhayeva Tamila, Kondo Hisayoshi, Nakashima Masahiro
Abstract excerpt
BACKGROUND: Papillary thyroid carcinoma (PTC) is the most prevalent subtype of thyroid carcinoma, constituting 80-85% of all cases. The clinical challenges posed by PTC are further compounded by its steadily increasing global incidence. Primarily associated with mutations in BRAF V600E and the TERT promoter (TERTp), the aggressive clinicopathological features and poor prognosis of PTC are exacerbated when these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
